Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 125, 2019 - Issue 1
476
Views
46
CrossRef citations to date
0
Altmetric
Original Article

The effects of some antibiotics from cephalosporin groups on the acetylcholinesterase and butyrylcholinesterase enzymes activities in different tissues of rats

, , & ORCID Icon
Pages 12-18 | Received 16 Dec 2017, Accepted 08 Jan 2018, Published online: 24 Jan 2018

References

  • Ahmed, T. and Gilani, A.H., 2009. Inhibitory effect of curcuminoids on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia may explain medicinal use of turmeric in Alzheimer’ disease. Pharmacology, biochemistry, and behavior, 91 (4), 554–559.
  • Aksu, K., et al., 2016. Antioxidant activity, acetylcholinesterase, and carbonic anhydrase inhibitory properties of novel ureas derived from phenethylamines. Archiv der pharmazie, 349 (12), 944–954.
  • Bayrak, Ç., et al., 2017. The first synthesis of 4-phenylbutenone derivative bromophenols including natural products and their inhibition profiles for carbonic anhydrase, acetylcholinesterase and butyrylcholinesterase enzymes. Bioorganic chemistry, 72, 359–366.
  • Budak, Y., et al., 2017. Synthesis and investigation of anti-bacterial activities and carbonic anhydrase and acetyl cholinesterase inhibition profiles of novel 4,5-dihydropyrazol and pyrazolylthiazole derivatives containing methanoisoindol-1,3-dion unit. Synthetic communications, 47 (24), 2313–2323.
  • Chaudhary, U. and Aggarwal, R., 2004. Extended spectrum β-lactamases (ESBL) – an emerging threat to clinical therapeutics. Indian journal of medical microbiology, 22, 75–80.
  • Erdemir, F., et al., 2018. 2-Hydroxyethyl substituted NHC precursors: synthesis, characterization, crystal structure and carbonic anhydrase, α-glycosidase, butyrylcholinesterase, and acetylcholinesterase inhibitory properties. Journal of molecular structure, 1155, 797–806.
  • Garibov, E., et al., 2016. Synthesis of 4,5-disubstituted-2-thioxo-1,2,3,4-tetrahydropyrimidines and investigation of their acetylcholinesterase, butyrylcholinesterase, carbonic anhydrase I/II inhibitory and antioxidant activities. Journal of enzyme inhibition and medicinal chemistry, 31 (3), 1–9.
  • Gulçin, İ., et al., 2017. Synthesis and biological evaluation of aminomethyl and alkoxymethyl derivatives as carbonic anhydrase, acetylcholinesterase and butyrylcholinesterase inhibitors. Journal of enzyme inhibition and medicinal chemistry, 32 (1), 1174–1182.
  • Jackson, T.A., et al., 2016. Acetylcholinesterase activity measurement and clinical features of delirium. Dementia and geriatric cognitive disorders, 43 (1–2), 29–37.
  • Kandemir, M.F., et al., 2017. Therapeutic effects of silymarin and naringin on methotrexate-induced nephrotoxicity in rats: biochemical evaluation of anti-inflammatory, anti-apoptotic, and anti-autophagic properties. Journal of food biochemistry, 41 (5), e12398.
  • Koçyiğit, U.M. et al., 2017a. Inhibitory effects of oxytocin and oxytocin receptor antagonist atosiban on the activities of carbonic anhydrase and acetylcholinesterase enzymes in the liver and kidney tissues of rats. Journal of biochemical and molecular toxicology, 31 (11), e21972.
  • Kocyigit, U.M., et al., 2017b. Synthesis of chalcone-imide derivatives and investigation of their anticancer and antimicrobial activities, carbonic anhydrase and acetylcholinesterase enzymes inhibition profiles. Archives of physiology biochemistry, https://doi.org/10.1080/13813455.2017.1360914.
  • Kocyigit, U.M., et al., 2017c. Evaluation of acetylcholinesterase, and carbonic anhydrase inhibition profiles of 1,2,3,4,6-pentasubstituted-4-hydroxy-cyclohexanes. Journal of biochemical and molecular toxicology, 31 (9), e21938.
  • Koçyiğit, Ü.M., et al., 2018. Inhibitory effects of some drugs on carbonic anhydrase enzyme purified from Kangal Akkaraman sheep in Sivas, Turkey. Journal of biochemical and molecular toxicology, 32 (1), e22000.
  • Lang, C.C., Moreland, T.A., and Davey, P.G., 1990. Bioavailability of cefuroxime axetil: comparison of standard and abbreviated methods. The journal of antimicrobial chemotherapy, 25 (4), 645–650.
  • Massoud, G. and Gauthier, S., 2010. Update on the pharmacological treatment of Alzheimer's disease. Current neuropharmacology, 8 (1), 69–80.
  • Monden, Y., Fujimoto, Y., and Nakahara, K., 1986. Pharmacokinetics of cefoperazone concentration in human lung tissue. Japanese journal of antibiotics, 39, 57–62.
  • Obregon, A.D.C., et al., 2005. Effects per se of organic solvents in the cerebral acetylcholinesterase of rats. Neurochemical research, 30 (3), 379–384.
  • Orhan, I., et al., 2004. Acetylcholinesterase and butyrylcholinesterase inhibitory activity of some Turkish medicinal plants. Journal of ethnopharmacology, 91 (1), 57–60.
  • Özbey, F., et al., 2016. Synthesis, acetylcholinesterase, butyrilcholinesterase, carbonic anhydrase inhibitory and metal chelating properties of some novel diaryl ether. Journal of enzyme inhibition and medicinal chemistry, 31 (2), 79–85.
  • Öztaşkın, N., et al., 2015. Antioxidant and acetylcholinesterase inhibition properties of novel bromophenol derivatives. Bioorganic chemistry, 60, 49–57.
  • Pohanka, M., 2011. Cholinesterases, a target of pharmacology and toxicology. Biomedical papers of the medical faculty of the University Palacky, Olomouc, Czechoslovakia, 155 (3), 219–223.
  • Pohanka, M., 2012. Acetylcholinesterase inhibitors: a patent review (2008 – present)). Expert opinion on therapeutic patents, 22 (8), 871–886.
  • Racchi, M., et al., 2004. Acetylcholinesterase inhibitors: novel activities of old molecules. Pharmacological research, 50 (4), 441–451.
  • Sujayev, A., et al., 2016. Synthesis of some tetrahydropyrimidine-5-carboxylates, determination of their metal chelating effects and inhibition profiles against acetylcholinesterase, butyrylcholinesterase and carbonic anhydrase. Journal of enzyme inhibition and medicinal chemistry, 31 (6), 1531–1539.
  • Sun, L., Klein, E.Y., and Laxminarayan, R., 2012. Seasonality and temporal correlation between community antibiotic use and resistance in the United States. Clinical infectious diseases: an official publication of the infectious diseases society of America, 55 (5), 687–694.
  • Swann, M. M., Baxter, K. L., and Field, H. I., 1969. The report of the joint committee on the use of antibiotics in animal husbandry and veterinary medicine. London: Her Majesty’s Stationery Office.
  • Talpaert, M.J., et al., 2011. Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of clostridium difficile infection. The journal of antimicrobial chemotherapy, 66 (9), 2168–2174.
  • Tampi, R.R., Tampi, D.J., and Ghori, A.K., 2016. Acetylcholinesterase inhibitors for delirium in older adults. American journal of Alzheimer's disease and other dementias, 31 (4), 305–310.
  • Taslimi, P., et al., 2017a. The synthesis of new cyclic thioureas and evaluation of their metal-chelating activity, acetylcholinesterase, butyrylcholinesterase and carbonic anhydrase inhibition profiles. Journal of biochemical and molecular toxicology, 31 (7), e21897.
  • Taslimi, P., et al., 2017b. Synthesis and bioactivity of several new hetaryl sulfonamides. Journal of enzyme inhibition and medinal chemistry, 32, 137–145.
  • Taslimi, P., Akıncıoglu, H., and Gülçin, I., 2017c. Synephrine and phenylephrine act as α-amylase, α-glycosidase, acetylcholinesterase, butyrylcholinesterase and carbonic anhydrase enzymes inhibitors. Journal of biochemical and molecular toxicology, 31 (11), e21973.
  • Taslimi, P., Caglayan, C., and Gulçin, İ., 2017d. The impact of some natural phenolic compounds on carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase, and α-glycosidase enzymes: antidiabetic, anticholinergic, and antiepileptic potentials. Journal of biochemical and molecular toxicology, 31 (12), e21995.
  • Thu, T.A., et al., 2012. Antibiotic use in Vietnamese hospitals: a multicenter point-prevalence study. American journal of infection control, 40 (9), 840–844.
  • Tita, A.T., et al., 2009. Emerging concepts in antibiotic prophylaxis for cesarean delivery: a systematic review. Obstetrics and gynecology, 113 (3), 675–682.
  • Turan, B., et al., 2016. The synthesis of some β-lactams and investigation of their metal chelating activity, carbonic anhydrase and achetylcholinesterase inhibition profiles. Journal of enzyme inhibition and medicinal chemistry, 31 (1), 79–88.
  • Wong, K.K., et al., 2010. Interaction study of two diterpenes, cryptotanshinone, and dihydrotanshinone, to human acetylcholinesterase and butyrylcholinesterase by molecular docking and kinetic analysis. Chemico-biological interactions, 187 (1–3), 335–339.
  • Worek, F., et al., 1999. Improved determination of acetylcholinesterase activity in human whole blood. Clinica chimica acta, 288 (1–2), 73–90.
  • Yamali, C., et al., 2017. Synthesis, molecular modeling and biological evaluation of 4-[5-aryl-3-(thiophen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl]benzenesulfonamides towards acetylcholinesterase, carbonic anhydrase I and II enzymes. Chemical biology and drug design, https://doi.org/doi:10.1111/cbdd.13149.
  • Zheng, X.Y., et al., 2011. Identification of acetylcholinesterase inhibitors from seeds of plants of genus Peganum by thinlayer chromatography-bioautography. Journal of planar chromatography, 24 (6), 470–474.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.